Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
93.86
+1.06 (1.14%)
At close: Apr 28, 2026, 4:00 PM EDT
94.14
+0.28 (0.30%)
Pre-market: Apr 29, 2026, 5:24 AM EDT
Abbott Laboratories Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 163,472 | 217,859 | 196,184 | 191,088 | 191,427 | 241,365 | Upgrade
|
| Market Cap Growth | -24.29% | 11.05% | 2.67% | -0.18% | -20.69% | 28.66% | Upgrade
|
| Enterprise Value | 168,669 | 223,411 | 203,674 | 199,953 | 198,309 | 250,286 | Upgrade
|
| Last Close Price | 93.86 | 123.88 | 109.76 | 104.72 | 102.40 | 129.11 | Upgrade
|
| PE Ratio | 26.29 | 33.52 | 14.64 | 33.52 | 27.72 | 34.28 | Upgrade
|
| Forward PE | 16.74 | 22.63 | 22.39 | 24.22 | 26.64 | 30.05 | Upgrade
|
| PS Ratio | 3.62 | 4.92 | 4.68 | 4.76 | 4.39 | 5.60 | Upgrade
|
| PB Ratio | 3.13 | 4.13 | 4.10 | 4.92 | 5.19 | 6.70 | Upgrade
|
| P/TBV Ratio | 7.24 | 9.65 | 10.96 | 31.28 | 55.76 | - | Upgrade
|
| P/FCF Ratio | - | 29.46 | 30.89 | 37.77 | 24.53 | 27.91 | Upgrade
|
| P/OCF Ratio | - | 22.77 | 22.92 | 26.32 | 19.98 | 22.92 | Upgrade
|
| PEG Ratio | 1.69 | 2.35 | 2.61 | 2.85 | 5.16 | 2.38 | Upgrade
|
| EV/Sales Ratio | 3.74 | 5.04 | 4.86 | 4.99 | 4.54 | 5.81 | Upgrade
|
| EV/EBITDA Ratio | 13.88 | 18.57 | 19.01 | 19.11 | 16.02 | 19.64 | Upgrade
|
| EV/EBIT Ratio | 18.71 | 25.05 | 27.17 | 27.69 | 21.76 | 27.19 | Upgrade
|
| EV/FCF Ratio | - | 30.21 | 32.07 | 39.52 | 25.41 | 28.94 | Upgrade
|
| Debt / Equity Ratio | 0.27 | 0.27 | 0.32 | 0.41 | 0.49 | 0.53 | Upgrade
|
| Debt / EBITDA Ratio | 1.13 | 1.14 | 1.38 | 1.48 | 1.41 | 1.47 | Upgrade
|
| Debt / FCF Ratio | - | 1.91 | 2.41 | 3.16 | 2.30 | 2.23 | Upgrade
|
| Net Debt / Equity Ratio | 0.10 | 0.10 | 0.15 | 0.22 | 0.21 | 0.25 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.43 | 0.43 | 0.69 | 0.83 | 0.63 | 0.71 | Upgrade
|
| Net Debt / FCF Ratio | - | 0.70 | 1.16 | 1.72 | 1.00 | 1.04 | Upgrade
|
| Asset Turnover | - | 0.53 | 0.54 | 0.54 | 0.58 | 0.58 | Upgrade
|
| Inventory Turnover | - | 3.03 | 2.92 | 2.81 | 3.37 | 3.56 | Upgrade
|
| Quick Ratio | - | 1.02 | 1.05 | 1.00 | 1.06 | 1.28 | Upgrade
|
| Current Ratio | - | 1.58 | 1.67 | 1.64 | 1.63 | 1.85 | Upgrade
|
| Return on Equity (ROE) | - | 12.96% | 30.91% | 15.11% | 19.01% | 20.49% | Upgrade
|
| Return on Assets (ROA) | - | 6.63% | 6.06% | 6.11% | 7.61% | 7.79% | Upgrade
|
| Return on Invested Capital (ROIC) | 11.99% | 12.14% | 14.59% | 13.45% | 16.96% | 17.46% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 12.70% | 11.10% | 12.20% | 15.50% | 14.80% | Upgrade
|
| Earnings Yield | 3.82% | 3.00% | 6.83% | 3.00% | 3.62% | 2.93% | Upgrade
|
| FCF Yield | - | 3.39% | 3.24% | 2.65% | 4.08% | 3.58% | Upgrade
|
| Dividend Yield | 2.69% | 1.94% | 2.04% | 1.99% | 1.88% | 1.41% | Upgrade
|
| Payout Ratio | 68.35% | 63.09% | 28.62% | 62.13% | 47.73% | 45.28% | Upgrade
|
| Buyback Yield / Dilution | -0.03% | -0.06% | 0.06% | 0.85% | 1.40% | -0.17% | Upgrade
|
| Total Shareholder Return | 2.65% | 1.88% | 2.10% | 2.84% | 3.27% | 1.24% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.